Nanozymes: Innovative Therapeutics in the Battle Against Neurodegenerative Diseases
International Journal of Molecular Sciences · 09.04.2025 · 26 (8) · 3522
DOI: 10.3390/ijms26083522 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.04.2025. Verfasst von Carmen Duță und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Nanostructures. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 210 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and Huntington’s disease (HD), represent a significant challenge to global health due to their progressive nature and the absence of curative treatments. These disorders are characterized by oxidative stress, protein misfolding, and neuroinflammation, which collectively contribute to neuronal damage and death. Recent advancements in nanotechnology have introduced nanozymes—engineered nanomaterials that mimic enzyme-like activities—as promising therapeutic agents. This review explores the multifaceted roles of nanozymes in combating oxidative stress and inflammation in neurodegenerative conditions. By harnessing their potent antioxidant properties, nanozymes can effectively scavenge reactive oxygen species (ROS) and restore redox balance, thereby protecting neuronal function. Their ability to modify surface properties enhances targeted delivery and biocompatibility, making them suitable for various biomedical applications. In this review, we highlight recent findings on the design, functionality, and therapeutic potential of nanozymes, emphasizing their dual role in addressing oxidative stress and pathological features such as protein aggregation. This synthesis of current research underscores the innovative potential of nanozymes as a proactive therapeutic strategy to halt disease progression and improve patient outcomes in neurodegenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
ORCID-Profile: Carmen Duță, Irina Stoian
Zitieren
APA
Duță, C., Dogaru, C. B., Muscurel, C., & Stoian, I. (2025). Nanozymes: Innovative Therapeutics in the Battle Against Neurodegenerative Diseases. International Journal of Molecular Sciences, 26(8), 3522. https://doi.org/10.3390/ijms26083522
Vancouver
Duță C, Dogaru CB, Muscurel C, Stoian I. Nanozymes: Innovative Therapeutics in the Battle Against Neurodegenerative Diseases. International Journal of Molecular Sciences. 2025;26(8):3522. doi:10.3390/ijms26083522
BibTeX
@article{Du2025,
author = {Duță, Carmen and Dogaru, Carmen Beatrice and Muscurel, Corina and Stoian, Irina},
title = {Nanozymes: Innovative Therapeutics in the Battle Against Neurodegenerative Diseases},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {8},
pages = {3522},
doi = {10.3390/ijms26083522}
}
EUVIMED